Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Stock Report

| More

Panacea Biotec announces launch of ViLACT for treatment of Uncontrolled Type 2 Diabetes Mellitus patients

Posted On: 2019-12-10 17:32:02

Panacea Biotec has announced the launch of brand ViLACT in India. ViLACT is used in the treatment of Uncontrolled Type 2 Diabetes Mellitus patients with HbAlc >6.5%.

ViLACT is available in four formulations:

1. ViLACT Vildagliptin 50 mg Tablet.
2. ViLACTM 500 Vildagliptin 50 mg + Metformin HCL500 mg Tablet.
3. ViLACT M 850 Vildagliptin 50 mg + Metformin HCL850 mg Tablet.
4. ViLACTM 1000 Vildagliptin 50 mg + Metformin HCL1000 mg Tablet.

The total market size of this molecule and its combination is INR 969 Crore as per AIOCD MAT October '2019 and is growing at the rate of 4%. Vildagliptin product patent (IN 212815) in India has expired on 09th December '2019. Vildagliptin is a new oral antidiabetic agent that enhances pancreatic islet cell responsiveness to glucose, is an incretin enhancer, a potent and selective inhibitor of dipeptidyl peptidase-4 (DPP-4), the enzyme responsible for the rapid degradation of the incretin hormones glucagon-like peptide-1 (GLP-l) and glucose-dependent insulinotropic peptide (GIP). This activity increases levels of active incretins and enhances pancreatic islet α- and β-cell responsiveness to glucose, thus improving insulin secretion and reducing inappropriate glucagon production, improving insulin sensitivity, improving postprandial lipid and lipoprotein metabolism, and reducing fasting and prandial glucose and HbAlc.

Speaking on the occasion Dr. Rajesh Jain, Managing Director said: "Diacar Strategic Business Unit (SBU) has launched ViLACT brand family. This will open up a new segment for accelerated growth of the SBU.

I am pleased to share that during pre-launch activity that started in the month of October '2019, an innovative campaign was launched to protect our environment wherein 10,000 Doctors from all over India participated by pledging I "ViL ACT" to save the environment by planting over 10,000 plants, saying NO to plastic using Khadi bags, in the process giving boost to MSME sector as part of promoting use of Khadi.

In NewYear 2020, our aim is to reach 100,000 Doctors and plant over 100,000 saplings and we have created a website on this occasion.

Mr. Susheel Umesh, Chief Executive, Domestic Formulation said the ViLACT brand will be an affordable, high quality medicine in the armamentarium of a physician treating patients with Diabetes. The patients have always been and will continue to be the center of our business. The Physician needs a lot of options to bring down the burden of Diabetes and we with the ViLACT range will continue to support the patient and physician in this journey."

Shares of PANACEA BIOTEC LTD. was last trading in BSE at Rs.114.7 as compared to the previous close of Rs. 115.85. The total number of shares traded during the day was 13067 in over 513 trades.

The stock hit an intraday high of Rs. 122.3 and intraday low of 114.5. The net turnover during the day was Rs. 1540730.

Source: Equity Bulls

Click here to send ur comments or to

Other Headlines:

Abbott India Ltd posts Rs. 180.35 crore PAT in Q1FY21

FDC Limited to acquire further stake in South Africa firm

Energy Development Company Ltd board recommends dividend of Rs. 0.50

Hero MotoCorp donates unique first responder vehicles to Civil Hospital, Gurugram

Mirchi revenues fall 72%, but market share rises to 33%

FDC Ltd board approves buy-back at Rs. 450

Gujarat Themis Biosyn Ltd board to approve quarterly results on Aug 13, 2020

Ravileela Granites Ltd Q1 consolidated net profit up at Rs. 0.74 crore

Indowind Energy Ltd posts consolidated PAT of Rs. 3.40 crore in Q1

FDC Ltd reports consolidated PAT of Rs. 91.72 crore in Q1FY21

Mercury Laboratories Ltd Q1 PAT at Rs. 0.96 crore

BATA India Ltd reports loss of Rs. 100.88 crore in Q1FY21

Seshasayee Paper & Boards Ltd Q1FY21 consolidated net profit lower at Rs. 19.30 crore

ANUH Pharma Ltd board approves 1:1 bonus issue

Siemens Limited announces Q3 FY 2020 results, Performance impacted due to COVID-19

WINTAC Ltd Q1 loss at Rs. 0.3158 crore

Sudarshan Chemical Industries Ltd posts Rs. 18.19 crore consolidated PAT in Q1FY21

CIPLA Ltd Q1FY21 consolidated PAT up at Rs. 577.91 crore

DIC India Ltd Q2CY20 PAT soars on exceptional income

Andhra Paper Ltd reports loss in Q1FY21

Natural Capsules Ltd Q1FY21 net profit surges to Rs. 2.48 crore

The Shipping Corporation of India Ltd posts consolidated PAT of Rs. 336.87 crore in Q1FY21

ANUH Pharma Ltd Q1FY21 net profit up at Rs. 16.72 crore

RAMCO Industries Ltd Q1FY21 consolidated net profit rises to Rs. 61.83 crore

Container Corporation of India Ltd Q1FY21 consolidated PAT slides to Rs. 60.61 crore

Automotive Axles Ltd Q1 loss at Rs. 2.30 crore

Morganite Crucible India Ltd posts loss of Rs. 0.67 crore in Q1

Monte Carlo Fashions Ltd Q1FY21 loss at Rs. 13.53 crore

Nucleus Software Exports Ltd Q1FY21 consolidated PAT surges to Rs. 36.33 crore

Kesar Enterprises Ltd Q4FY20 PAT surges to Rs. 36.90 crore

Murugappa group firm to invest in CG Power and Industrial Solutions Ltd

Zensar to host Digital Foundation Services (DFS) Virtual Analyst and Advisor Conclave

JK Agri Genetics Ltd to raise funds upto Rs. 50 crore

Apollo Hopsital asks for 50% rent waiver

Shree Renuka Sugars Ltd to issue 2,11,670,481 Equity Shares at Rs. 8.74

REC Ltd Q1FY21 consolidated PAT soars to Rs. 1845.30 crore

Amara Raja Batteries Ltd Q1FY21 consolidated net profit declines to Rs. 62.49 crore

Aditya Birla Capital Ltd Q1FY21 consolidated net profit at Rs. 198.38 crore

Mangalam Cement Ltd posts net profit of Rs. 13.79 crore in Q1

Kaycee Industries Ltd Q1 loss at Rs. 0.20 crore

Nath Bio-Genes India Ltd Q1FY21 PAT rises to Rs. 41.25 crore

Birla Corporation Ltd reports earnings for Q1FY21

JK Agri Genetics Ltd Q1 PAT zooms to Rs. 19.20 crore

Finolex Industries Ltd posts consolidated PAT of Rs. 56.72 crore in Q1FY21

Shreyans Industries Ltd posts Rs. 6.77 crore PAT in Q1

Adani Transmission Ltd Q1FY21 consolidated PAT higher at Rs. 383.55 crore

Targeting the significant shift to Spiritual-Religious Tourism, Thomas Cook India & SOTC launch Ramayana Trails

Rane Madras Ltd announces Q1FY21 results

BHEL commences Civil Works at 660 MW Sagardighi Supercritical Thermal Power Plant in West Bengal

Equitas Small Finance Bank Limited is now the official retail banking partner of Chennai Super Kings

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019